Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Revenue: | ||||
| Total revenue | $ 2,550 | $ 1,597 | $ 8,036 | $ 4,900 |
| Cost of revenue: | ||||
| Total cost of revenue | 1,467 | 1,053 | 5,217 | 3,608 |
| Gross profit | 1,083 | 544 | 2,819 | 1,292 |
| Operating expenses: | ||||
| Sales and marketing | 3,106 | 3,226 | 10,892 | 9,563 |
| Research and development | 1,282 | 1,986 | 4,479 | 7,491 |
| General and administrative | 2,785 | 2,414 | 9,350 | 7,430 |
| Restructuring | 0 | 0 | 0 | 665 |
| Change in fair value, contingent consideration | 4 | (16) | (11) | (191) |
| Total operating expenses | 7,177 | 7,610 | 24,710 | 24,958 |
| Loss from operations | (6,094) | (7,066) | (21,891) | (23,666) |
| Other income (expense), net: | ||||
| Interest expense | (145) | (165) | (469) | (482) |
| Gain (loss) on warrant liabilities | (681) | 1,814 | (162) | 4,851 |
| Loss on repurchase of warrants | 0 | (1,067) | 0 | (1,067) |
| Other income (expense), net | (63) | 149 | (338) | 220 |
| Total other income (expense), net | (889) | 731 | (969) | 3,522 |
| Net loss | (6,983) | (6,335) | (22,860) | (20,144) |
| Foreign currency translation adjustments | 44 | (122) | 157 | (356) |
| Comprehensive loss | $ (6,939) | $ (6,457) | $ (22,703) | $ (20,500) |
| Basic and diluted net loss per share (in dollars per share) | $ (0.11) | $ (0.18) | $ (0.38) | $ (0.73) |
| Weighted average number of shares of common stock outstanding, basic and diluted (in shares) | 61,381 | 34,720 | 60,721 | 27,425 |
| Device and related | ||||
| Revenue: | ||||
| Total revenue | $ 2,533 | $ 1,587 | $ 8,008 | $ 4,862 |
| Cost of revenue: | ||||
| Total cost of revenue | 1,445 | 1,045 | 5,182 | 3,593 |
| Engineering services | ||||
| Revenue: | ||||
| Total revenue | 17 | 10 | 28 | 38 |
| Cost of revenue: | ||||
| Total cost of revenue | $ 22 | $ 8 | $ 35 | $ 15 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) from the difference between the repurchase price of warrant initially issued by the entity and the net carrying amount of the warrant at the time of its repurchase. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to other income activities, classified as other. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|